Executes the first project for developing and manufacturing a novel anticancer mAb
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The facility will manufacture tablets, capsules, and injections for the oncology segment
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Subscribe To Our Newsletter & Stay Updated